chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DEATH; This spontaneous report received from a consumer via social media, via a company representative concerned a patient of unspecified age, sex, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 in total, dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, it was reported that, "the Johnson and Johnson vaccine killed my neighbor plus, it was a one dose vaccine how did you have 2 injections", "the Johnson and Johnson vaccine killed my neighbor", "you got lucky...it killed my neighbor".  On an unspecified date, the patient died from unknown cause of death. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20220960539.; Sender's Comments: V0-20220960476-covid-19 vaccine ad26.cov2.s-Death. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Severe Nausea; Vomiting in the middle of the night; Extra congestion and headaches during the day; Extra congestion and headaches during the day; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 09Feb2021 at 09:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation and also received the third dose (booster dose) of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301258A) via an unspecified route of administration in the left arm on 05Oct2021 at 14:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the vaccination which included influenza vaccine (reported as flu shot) (MANUFACTURER UNKNOWN) on 01Oct2021 for immunization. The patient did not receive other medications in two weeks of vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in left arm on 19Jan2021 at 08:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, after the second dose, the patient experienced severe nausea, vomiting in the middle of the night, extra congestion and headaches during the day. On 06Oct2021 at 01:00, after the third dose (booster dose), same events occurred. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe nausea, vomiting in the middle of the night and extra congestion and headaches during the day was resolving at the time of this report.
Developed severe vasculitis 12 hours after getting the vaccine and subsequent neuropathy in both feet
****Caller did not want to provide any personal information. ****Soreness began 24hrs after inj.  Warm to the touch and hard at the inj site.  3hrs later became so sleepy like someone gave her a drug.  It lasted a few hours.  Palms and neck got itchy for a few hour. Had loose stools.   This lasted for about 6 hours in total.
Information has been received from a practice manager concerning a 22 year old female patient who on 06-FEB-2009 was vaccinated with her first dose of GARDASIL (lot number 661766/0652X, route not reported) in her left deltoid.  The patient developed left leg soreness starting from her hip and left leg tingling beginning that first night.  She was sore for two days and then the symptoms resolved.  The patient would be seen in office on the reporting date.  Additional information has been requested.
One month post vax, the pt developed reactive arthritis in the wrists, ankles, and feet and was dx with reactive arthritis (systemic lupus erythematosus).
Information has been received from a physician via a company representative concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history or concomitant medications were not reported. On 28-JAN-2014, the patient was vaccinated with a dose of PNEUMOVAX 23 2.5 ml, five dose vial, (lot number J004332, with an expiration date of 26-SEP-2014) (route and anatomical location of administration were not reported) that was improperly stored. The lowest temperature excursion was of 32 degrees Fahrenheit (F) (0 Celsius) for a total of 72 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. Furthermore, no product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Started receiving rash/blister under armpits about a week after shot.  Two weeks later, blisters starting spreading to groin area and at lymph node areas.  Blisters popping and starting to itch.  Resembles shingles.
Pt vaccinated with DTP/OPV developed high pitched screaming & temp >104 for several hrs.
Nurse drawing up Moderna doses drew up and administered wrong dose Patient was notified 10/06/21 and offered to received the additional mL to receive the full dose.
Weakness and sick all the day after the vaccination,  temperature 99-101,  night sweats that night, nausea and throwing up.  I was not able to go anywhere.  Stayed in bed or my recliner all day.  Also had a very sore arm for four days.   I only took a couple aspirin to keep my temperature down. On the second day I was up and around, but still felt weak.
Red spot, about half an inch long and a quarter inch wide; getting bigger; burning and not going away; Red spot, about half an inch long and a quarter inch wide; getting bigger; burning and not going away; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 71-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN5318, Expiry Date: Unknown) via an unspecified route of administration in arm on 28Jan2021 (at the age of 71-year-old) as a single dose for COVID-19 immunization. Patient medical history included Cholesterol (blood cholesterol). Patient was a veteran (VA). The concomitant medications included cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]) and a cholesterol medicine. It was reported that patient was taken other products. He got both vaccines through the VA. Patient received first dose on shoulder 4 inches below from where they are supposed to give it. On an unspecified date in 2021, after the first dose patient experienced red spot, about half an inch long and a quarter inch wide. It started about maybe a week or so that he had it and that was just a red spot and now it had turned into a mark about I say half an inch long and about a quarter inch wide, getting bigger, burning and not going away, it's not round it's like a rugged. Patient went back down to the VA and they were put him on 3 medications and a cream for 3 or 4 times a day and it still burns; seems like that's not even helping. First of all, they said pat it with warm water and then put this cream on. And he was just wondering, that care for these ones can get a couple of more days and could probably go back down but frankly he does not know what's going on. No investigation assessment was done. The patient was administered with second dose on 17Feb2021 with lot number: EN9581. The clinical outcome of all events was not recovered (still burning).  No follow-up attempts are possible. No further information is expected.
allergic reaction; swelling; This is a spontaneous report from a non-contactable pharmacist. A patient of unspecified age and gender receive the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had an allergic reaction on an unspecified date, after receiving the 1st dose of vaccine. The patient experienced swelling. The reporter wanted to know if it is still advisable for the patient to get the 2nd dose of the vaccine. The patient did covid testing the same day he received his 1st dose, patient tested negative. Outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a consumer refers to her husband of unknown age. On 18-SEP-2014 the patient was vaccinated with ZOSTAVAX (lot #, expiration date, dose and route unspecified). On 18-SEP-2014, the patient developed a rash around the mouth area. The patient had sought medical attention. VALTREX was given for treatment. The outcome of a rash around the mouth area was reported as recovered in September 2014. Additional information has been requested.
Very sore arm. Movement limited. Four physical therapy sessions. Still bothersome five months later.
8MAR94 mom stated that pt  cried non-stop for 4 hrs striaght; that pt vomited & had a t101 ax x 24 hrs; mom said was concerned;
I started having a hard time breathing that got progressively worse and in March I went to the DR,  I had two cardiac stents put in and was given medication, at some point they said I had a heart attack but they do not know if it was after or before the shot.
Patient received expired Boostrixdose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 64-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis.   On 7th July 2022, the patient received Boostrix. On 7th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 7-Jul-2022 Reporter's comment: The nurse reported that the patient received an expired dose of Boostrix vaccine in left deltoid. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Boostrix, which led to expired vaccine used.
Approximately three (3) weeks after receiving second Moderna vaccine for COVID-19, I experienced pain in my lower right abdomen that resulted in an emergency gallbladder removal procedure on May 14, 2021. This procedure occurred at the Medical Center .   On June 1, 2021, I experienced chills, fever and continued pain in the abdomen area that resulted in an infection. I was hospitalized immediately, the infection (~1000mls) was drained and i was monitored in the ICU for 6 days. I was sent home with a drain where I continue to experience pain in the lower right portion of my abdomen. As of today, June 16, 2021, i continue to experience some pain around where the gallbladder was removed and it continues to drain.
Scattered petechial spots in both legs with thrombocytopenia with platelets count of 91000.; Scattered petechial spots in both legs with thrombocytopenia with platelets count of 91000.; This is a spontaneous report from a contactable consumer. A 60-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number ER8737, on 02Apr2021 13:00 at single dose in left arm for COVID-19 immunization. Medical history included myocardial infarction, hyperthyroidism, allergy to Contrast agent. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN (E.C.)), clopidogrel bisulfate (PLAVIX), atorvastatin, pantoprazole sodium sesquihydrate (CONORAN), sertraline. The patient experienced Scattered petechial spots in both legs with thrombocytopenia with platelets count of 91000 on 13Apr2021. The outcome of the events was unknown.
Significant pain to (R) shoulder where vaccine was administered. Lasted 3 days then resolved without treatment.
body aches and pretty much both arms mostly in bilateral upper extremities/specifically like mid-day when it get worse and it started like wrist and elbow pain; body aches and pretty much both arms mostly in bilateral upper extremities/specifically like mid-day when it get worse and it started like wrist and elbow pain; body aches and pretty much both arms mostly in bilateral upper extremities/specifically like mid-day when it get worse and it started like wrist and elbow pain; body aches and pretty much both arms mostly in bilateral upper extremities/specifically like mid-day when it get worse and it started like wrist and elbow pain; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 31 year-old male patient received bnt162b2 (COMIRNATY), administered in deltoid left, administration date 27Sep2021 (Lot number: WM1247) at the age of 31 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Guillain-Barre" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; PROXIFEN 65. Vaccination history included: Bnt162b2 (Dose:01), administration date: 09Jan2021, when the patient was 30 years old, for Covid-19 immunization; Bnt162b2 (Dose:02), administration date: 30Jan2021, when the patient was 30 years old, for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 2021, outcome "unknown" and all described as "body aches and pretty much both arms mostly in bilateral upper extremities/specifically like mid-day when it get worse and it started like wrist and elbow pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, pain, arthralgia.  Additional Information:The patient stated that was no weakness, numbness, no pain going, just body aches. She was taking Ibuprofen as treatment medication. No prior vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a physician via two company representatives and from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 22-JUN-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/1 ml injection, lot # L044917, expiration date 05-OCT-2018 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to three temperature excursions (dates unspecified): the first lasting for 168 hours, with the lowest recorded temperature of 32 degrees Fahrenheit (0 degrees Celsius), the second lasting for 192 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.111111111 degrees Celsius) and the third lasting for 24 hours, with the lowest recorded temperature of 30 degrees Fahrenheit (-1.111111111 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
I received the injection in the left deltoid and have had joint pain in my left elbow since a few days after the injection. I have pain/discomfort each time I extend my left arm. I have used OTC pain medicine with no relief.
No doses were administered/ never actually gave the patient the shot.; give to a patient 25 days after first; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Mar-2021. The most recent information was received on 04-Aug-2021 and was forwarded to Moderna on 04-Aug-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (give to a patient 25 days after first) and PRODUCT DOSE OMISSION ISSUE (No doses were administered/ never actually gave the patient the shot.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (give to a patient 25 days after first). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (No doses were administered/ never actually gave the patient the shot.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (give to a patient 25 days after first) and PRODUCT DOSE OMISSION ISSUE (No doses were administered/ never actually gave the patient the shot.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided..   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Significant follow up received on 04-AUG-2021 contain new event information.
The patient is 11 years 9 months and was given the incorrect vaccine. He should have received the 5 to 11 year old solution 0f 0.2 ml. Instead he received the 12 t solution of 0.3 ml the child is robust and overweight
Patient received her vaccinations and became inconsolable for 1 hour and passed out with some jerking motions. Regained consciousness on her own. Mom reported child having a fever for 30 hours total, as high as 104.8 with small relief from acetaminophen. Mother was able to manage child's condition at home without Dr or ER visit. Mother also reports a welt 1 inch in diameter around the DTaP injection site.
Took ibuprofen and drank 16 oz of water 1 hour prior to appointment Appointment at 2:30PM PST Felt fine immediately following vaccine (30 minutes after injection) At 4:30PM PST, I began feeling tired At 6PM PST I felt feverish, took temperature around 9PM PST and had mild fever of 99.4 (taken in ear) At 9PM PST body aches set in and moderate physical discomfort (couldn't get comfortable, took ibuprofen) 9:30PM PST (ish) fell asleep.  Woke up at 3:15AM PST when my fever broke, drenched in sweat. For the past five days I have had extreme exhaustion and a mild persistent headache (Tuesday - Saturday [today])
2 days after receiving injection of DTAP in the left arm the child had a large area of redness, warmth, and swelling in the left deltoid muscle.
Patient fainted within five minutes after received 1st dose of Moderna. Patient stated that had previous fainting episodes "when dealing with needles" and previously fainted during blood collection at a lab. Also, he stated that didn't eat anything that day.  He stated that felt better after about 10-15 minutes. He was observed for 1 hour, was provided water and crackers.
Slight pain in wrists, toes, fee, ankles, fingers; sharp pain in heart
Large fist size circle, maybe the size of an orange; developed a rash / large fist size circle, maybe the size of an orange; Sore again / Quite tender; Tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tender arm), INJECTION SITE PAIN (Sore again / Quite tender), INJECTION SITE RASH (developed a rash / large fist size circle, maybe the size of an orange) and RASH (Large fist size circle, maybe the size of an orange) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced TENDERNESS (Tender arm). On 15-Feb-2021, the patient experienced INJECTION SITE PAIN (Sore again / Quite tender). On 16-Feb-2021, the patient experienced INJECTION SITE RASH (developed a rash / large fist size circle, maybe the size of an orange). On 17-Feb-2021, the patient experienced RASH (Large fist size circle, maybe the size of an orange). On 10-Feb-2021, TENDERNESS (Tender arm) had resolved. At the time of the report, INJECTION SITE PAIN (Sore again / Quite tender), INJECTION SITE RASH (developed a rash / large fist size circle, maybe the size of an orange) and RASH (Large fist size circle, maybe the size of an orange) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
got both shots, hes is getting over a bad case of shingles/suspected vaccination failure; shingles in he had them up & down his right arm & a large patch on his right; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The reporter said sorry but the shots did not always work, her husband got both shots a few years ago but he was just getting over a bad case of shingles, he had them up and down his right arm also a large patch on his right shoulder blade. This case was considered as suspected vaccination failure as time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.
Child received injections in each arm on 01/11/05, DTaP, IM ,Left arm; Varicella, SQ, left arm: Prevnar, IM, left arm, IPV, IM, right arm; MMR, SQ, right arm. The next day she had cellulitis of both arms. The patient was treated with Keflex 250mg, warm soaks or ice as needed and Tylenol or Ibuprofen.